Getting approved for Ozempic specifically for weight loss is more complicated than many people expect, because Ozempic is not FDA-approved for weight loss. It’s approved only for adults with type 2 diabetes to improve blood sugar control and reduce cardiovascular risk. The same active ingredient, semaglutide, is sold under the brand name Wegovy at a higher dose for weight management. That distinction shapes every step of the approval process, from your doctor’s willingness to prescribe it to whether your insurance will cover it.
Why Ozempic and Wegovy Matter as Separate Drugs
Ozempic and Wegovy contain the same compound, but the FDA treats them as different medications with different approved uses. Ozempic is dosed for diabetes management, while Wegovy is dosed specifically for chronic weight management. When a doctor prescribes Ozempic for weight loss, that’s considered “off-label” use, meaning it’s legal and common but not what the drug was designed and approved for.
This matters because insurance companies base their coverage decisions on FDA-approved indications. If you don’t have type 2 diabetes, most insurers will not cover Ozempic. They may, however, cover Wegovy for weight loss if you meet certain criteria. Understanding which drug you’re actually pursuing will save you time and frustration.
BMI and Health Criteria for Semaglutide
Whether you’re seeking Ozempic off-label or Wegovy by name, prescribers generally follow the same weight management guidelines. You typically need a BMI of at least 30, or a BMI of at least 27 with at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea.
For people of South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds, BMI thresholds are often lowered by 2.5 points. This reflects research showing these populations develop weight-related metabolic problems at lower BMIs than the general population. So the threshold drops to roughly 27.5 (or 24.5 with a comorbidity).
If your BMI is borderline, documenting related health conditions strengthens your case significantly. A history of prediabetes, elevated fasting glucose, or insulin resistance can make the difference between approval and denial.
What Insurance Companies Require
Insurance approval for Ozempic almost always requires a diagnosis of type 2 diabetes. A representative policy from Aetna illustrates the standard hurdles: you need a type 2 diabetes diagnosis, plus you must show that first-line treatments like metformin didn’t work, caused side effects, or were medically inappropriate. Alternatively, you qualify if your A1C is 7.5% or higher and you need combination therapy, or if you have established cardiovascular disease.
If you’ve already been on a similar medication for at least three months, insurers want to see that your A1C has actually improved. They’re checking that the drug is working before continuing to pay for it.
For weight loss without diabetes, most commercial insurers will deny Ozempic coverage outright. Some plans cover Wegovy for obesity, but many still exclude weight loss medications entirely. Before your appointment, call your insurance company and ask two specific questions: Does my plan cover Ozempic for off-label weight loss? Does my plan cover Wegovy for weight management? The answers will determine your best path forward.
The Prior Authorization Process
Even with the right diagnosis, most insurers require prior authorization before they’ll pay. Your doctor’s office submits documentation showing you meet the criteria: your diagnosis, lab results, medication history, and evidence that other treatments were tried first. This process takes anywhere from a few days to a few weeks. If denied, your doctor can file an appeal with additional clinical justification. Many initial denials are overturned on appeal, so don’t treat a first rejection as the final answer.
Which Doctors Can Prescribe It
Any licensed physician, nurse practitioner, or physician assistant can legally prescribe Ozempic. In practice, your chances of getting a thorough evaluation and a well-supported prescription are higher with certain specialists. Obesity medicine specialists, endocrinologists, and gastroenterologists have the deepest expertise in how these medications work and which patients benefit most. The American Medical Association specifically recommends seeking out an obesity board-certified provider or endocrinologist who can provide consistent follow-up.
That said, many primary care doctors now prescribe semaglutide regularly. If you have an established relationship with a PCP who knows your medical history, that’s a reasonable starting point. They can refer you to a specialist if needed.
Getting a Prescription Through Telehealth
Telehealth platforms have become a popular route, especially for people whose local doctors are reluctant to prescribe weight loss medications. Legitimate services follow a structured process: an initial virtual consultation where a clinician reviews your medical history, current medications, allergies, and any conditions that would make semaglutide unsafe (such as a personal or family history of certain thyroid cancers or pancreatitis).
Most reputable platforms require lab work before prescribing, particularly for first-time users. Expect to provide recent A1C results, kidney function tests, and sometimes liver function panels. Some states require an initial in-person exam before controlled or specialty medications can be prescribed via telehealth, so check your state’s regulations. Be wary of any service that offers a prescription without reviewing labs or asking detailed medical questions. That’s a red flag, not a shortcut.
What It Costs Without Insurance
Ozempic’s list price makes out-of-pocket payment steep, but the manufacturer offers a savings program through NovoCare. With commercial insurance, you may pay as little as $25 per month for up to three months, with a maximum savings of $100 per month. Without any insurance, the self-pay price through the NovoCare Pharmacy starts at $149 per month for new patients on lower doses (0.25 mg and 0.5 mg), at $199 per month for the first two fills. After the introductory period, prices rise to $349 per month for the 0.25 mg, 0.5 mg, or 1 mg doses, and $499 per month for the 2 mg dose.
There are important eligibility restrictions. You cannot use the savings card if you’re on any government insurance, including Medicare, Medicaid, VA benefits, TRICARE, or DOD programs. People with both commercial and government plans are also excluded. Federal Employees Health Benefits (FEHB) plans and Affordable Care Act marketplace plans are not considered government programs for purposes of this offer, so those members can participate.
Steps to Improve Your Chances
If you’re serious about getting approved, preparation matters more than most people realize. Before your appointment, gather documentation of any weight-related health conditions, previous weight loss attempts (structured programs, other medications, dietary interventions), and recent lab work. Insurers and prescribers both want to see that you’ve tried lifestyle changes and that your weight is causing or worsening medical problems.
At your appointment, be specific about how your weight affects your health and daily functioning. A vague request for a weight loss drug is easy to deflect. A documented history of rising blood pressure, worsening joint pain, or prediabetes despite consistent effort gives your doctor the clinical justification they need to write the prescription and fight for insurance coverage on your behalf.
If you’re denied by insurance, ask your doctor about Wegovy as an alternative since it carries the FDA weight management indication that Ozempic lacks. Some patients also find success switching to a different insurer during open enrollment if their current plan categorically excludes weight loss medications. Employer-sponsored plans vary widely, and some have added obesity medication coverage in recent years as the evidence base for these drugs has grown.
Supply Shortages and Filling Your Prescription
Even after getting approved, you may run into supply issues. Semaglutide products have experienced intermittent shortages due to surging demand. The FDA maintains an active drug shortage database where you can check current availability by searching the generic name “semaglutide.” If your pharmacy can’t fill the prescription, ask them to check other locations or contact the manufacturer directly. Your prescriber may also be able to adjust your dose temporarily to a formulation that’s currently in stock, or switch between Ozempic and Wegovy depending on availability.